globalbarry. Company Intelligence Engine

REPLIGEN CORP

RGEN CIK 0000730272 · Biological Products, (No Diagnostic Substances) (SIC 2836)

Disclosed SEC business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453

REPLIGEN CORP (ticker RGEN, CIK 0000730272) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

104 exposure relationships mapped 104 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
  • FACT Country of disclosed business address: United States
  • FACT 4 filed (period 2026-10-06) 2026-10-08 source ↗

You've reached this month's free company deep views

The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.

Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.